These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB. J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050 [Abstract] [Full Text] [Related]
4. The pharmacology of alprazolam: a review. Huybrechts I. Clin Ther; 1991 Apr; 13(1):100-17. PubMed ID: 2029716 [Abstract] [Full Text] [Related]
5. The relationship of alprazolam dose to steady-state plasma concentrations. Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ. J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754 [Abstract] [Full Text] [Related]
8. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam. Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH. J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428 [Abstract] [Full Text] [Related]
9. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Salvà P, Costa J. Clin Pharmacokinet; 1995 Sep; 29(3):142-53. PubMed ID: 8521677 [Abstract] [Full Text] [Related]
10. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI. J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021 [Abstract] [Full Text] [Related]
12. Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ. Br J Clin Pharmacol; 1995 Sep; 40(3):231-6. PubMed ID: 8527284 [Abstract] [Full Text] [Related]
13. Lack of interaction between disulfiram and alprazolam in alcoholic patients. Diquet B, Gujadhur L, Lamiable D, Warot D, Hayoun H, Choisy H. Eur J Clin Pharmacol; 1990 Sep; 38(2):157-60. PubMed ID: 2338112 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers. Glue P, Fang A, Gandelman K, Klee B. Am J Ther; 2006 Sep; 13(5):418-22. PubMed ID: 16988537 [Abstract] [Full Text] [Related]
15. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam. Abernethy DR, Greenblatt DJ, Divoll M, Moschitto LJ, Harmatz JS, Shader RI. Psychopharmacology (Berl); 1983 Sep; 80(3):275-8. PubMed ID: 6137021 [Abstract] [Full Text] [Related]
16. Fluoxetine impairs clearance of alprazolam but not of clonazepam. Greenblatt DJ, Preskorn SH, Cotreau MM, Horst WD, Harmatz JS. Clin Pharmacol Ther; 1992 Nov; 52(5):479-86. PubMed ID: 1424422 [Abstract] [Full Text] [Related]
17. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam. DeVane CL, Ware MR, Lydiard RB. Psychopharmacol Bull; 1991 Nov; 27(4):463-73. PubMed ID: 1687613 [Abstract] [Full Text] [Related]
18. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Mahmood I, Sahajwalla C. Clin Pharmacokinet; 1999 Apr; 36(4):277-87. PubMed ID: 10320950 [Abstract] [Full Text] [Related]
19. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I). Greenblatt DJ, Harmatz JS, Shader RI. Clin Pharmacokinet; 1991 Sep; 21(3):165-77. PubMed ID: 1684924 [Abstract] [Full Text] [Related]